References
- Coyle JT, Puttfarcken P. Oxidative stress, glutamate and neurodegenerative disorders. Science 1993; 262: 689-695.
- Shaw PJ, Eggett CG. Molecular factors underlying selective vulnerability of motor neuron to neuro degeneration in amyotrophic lateral sclerosis. J Neurol 2000; 247: S1-117-127.
- Plaitakis A. Glutamate dysfunction and selective motorneuron degeneration in amyotrophic lateral sclerosis: a hypothesis. Ann Neurol 1990; 28: 3-8.
- Rothstein JD, Tsai G, Kuncl RW, et al. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol 1990; 28: 18-25.
- Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med. 1992; 326: 1464-1468.
- Rothstein JD, Martin LJ, Dykes-Hoberg M, et al. Glutamate transporter subtypes: role in excitotoxicity and amyotrophic lateral sclerosis. Ann Neurol 1994; 36: 282.
- Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW. Chronic glutamate uptake inhibition produces a model of slow neuro toxicity. Proc Natl Acad Sci USA 1993; 90: 6591-6595.
- Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995; 38: 73-84.
- Lin CI, Bristol LA, Jin L, Dykes-Hoberg M, et al. Aberrant RNA Processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 1998; 20: 589-602.
- Gurney ME, Cutting FB, Ping Zhai, et al. Bene.t of vitamin E, riluzole and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 1996; 39: 147-157.